ResMed to Report Second Quarter Fiscal 2023 Earnings on January 26, 2023
ResMed (NYSE: RMD) will release its financial and operational results for Q2 FY2023 on January 26, 2023, after NYSE closure. A webcast will follow to discuss these results, starting at 1:30 p.m. PDT (4:30 p.m. EDT). The event will also cover additional forward-looking and material information. Investors can access the webcast at ResMed's investor website. A replay will be available two hours post-webcast, along with a phone replay until February 9, 2023.
- None.
- None.
SAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2023 on Thursday, January 26, 2023, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
| http://investor.resmed.com |
| Thursday, January 26, 2023 |
| 1:30 p.m. PDT / 4:30 p.m. EDT |
| London, Thursday, January 26, 2023, 9:30 p.m. GMT |
| Sydney, Friday, January 27, 2023, 8:30 a.m. AEDT |
Please note: ResMed does not use outside phone lines to access the earnings call; the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from January 26, 2023, until February 9, 2023, at:
- U.S.: +1 877.660.6853
- International: +1 201.612.7415
- Conference ID: 13735371
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media |
| Amy Wakeham | Jayme Rubenstein |
| +1 858.836.5000 | +1 858.836.6798 |
| investorrelations@resmed.com | news@resmed.com |
FAQ
When will ResMed release its Q2 FY2023 financial results?
What time is the ResMed Q2 FY2023 earnings webcast?
How can I access the ResMed earnings webcast?
Will there be a replay of the ResMed earnings call?
What is the conference ID for the ResMed earnings call?
